Piotr Hadaczek, PhD
|School||UCSF School of Medicine|
|Address||1855 Folsom Street|
San Francisco CA 94103
|University of California San Francisco, Dept. of Neurosurgery||Postdoctoral Fellow||2001||Gene Therapy of the CNS|
|Thomas Jefferson University, Kimmel Cancer Center||Postdoctoral Fellow||1996||Cancer Genetics|
|Pomeranian Medical University, Szczecin, Poland, Dept. of Genetics and Pathology||Ph.D. (cum laude)||1995||Cancer Genetics|
|University of Szczecin, Poland, Dept. of Biology||M.Sc.||1992||Biology|
|Pomeranian Academy of Medicine, Szczecin, Poland||1995
||1995||Scientific Award of Rector of PAM|
|Pomeranian Academy of Medicine, Szczecin, Poland||1996
||1996||Scientific Award of Rector of PAM|
|Polish Ministry of Health and Social Care||1997
||1997||Award of Ministry of Health and Social Care|
|Foundation for Polish Science||1998
||1998||Scholarship of Foundation for Polish Science|
|Polish Ministry of Health and Social Care||1999
||1999||Award of Ministry of Health and Social Care|
|Polish Ministry of Health and Social Care||2000
||2000||Award of Ministry of Health and Social Care|
My research experience has been focused for many years on translational neuroscience. I have participated extensively in the creation of novel approaches for the delivery of therapeutic agents to specific target regions within the brain to develop effective treatments for brain diseases. In addition, I have developed release assays for clinical gene therapy products, and I am an expert on analytical method development and optimization. I have run and supervised many projects (preclinical studies) that, with the help of industry partners (Avigen, Genzyme), culminated in a clinical trial at UCSF and another at NIH. In that context, I have acquired considerable expertise in the supervision of technical staff and managing small research groups. I am very confident in my ability to direct R&D programs in the neuroscience (Parkinson’s disease) and oncology (brain tumor) fields. My main interest has been in the treatment of Parkinson’s disease via gene transfer and direct infusion of neurotrophic factors to counter neurodegeneration, and it is the area in which I have published many of my papers.
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.